Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

Remdesivir, Hydroxychloroquine show no antiviral effect against Covid-19: Study

by AIP Online Bureau | Jul 13, 2021 | Eco/Invest/Demography, Facts, Health, Non-Life, Pandemic

  LONDON: Remdesivir and Hydroxychloroquine (HCQ) showed no antiviral activity in hospitalised patients with Covid-19 in Norway, according to a study published on Tuesday. While HCQ is used to prevent or treat malaria, Remdesivir is sold as an antiviral drug. The...

Vaccinated and confused? Answers about masks, Delta variant and breakthrough infections

by AIP Online Bureau | Jul 13, 2021 | Articles, Eco/Invest/Demography, Health, Life, Non-Life, Pandemic

The World Health Organization wants everybody to wear masks, but the U.S. Centers for Disease Control and Prevention says vaccinated people often don’t need to wear them. So whom do we listen to? Virus experts and public health researchers also offer mixed...

Ever Given container ship leaves Egyptian waters months after blocking Suez Canal

by AIP Online Bureau | Jul 13, 2021 | Eco/Invest/Demography, International News

  ISMAILIA: The Ever Given container ship that had blocked the Suez Canal in March left Egyptian waters at 4 a.m. local time following inspections at Port Said, a canal source said on Tuesday. Ship tracker MarineTraffic showed the Ever Given to be underway in the...

Maha unveils new EV policy, sets 10 pc share in total registrations by 2025

by AIP Online Bureau | Jul 13, 2021 | Eco/Invest/Demography, Indian News, Non-Life, Technology

The Maharashtra government on Tuesday announced its new electric vehicle (EV) policy with an aim of making such vehicles achieve 10 per cent share of total registrations by 2025. The new policy, which has updated the one announced in 2018, was released by Additional...

Medicare evaluating coverage for $56,000 Alzheimer’s drug

by AIP Online Bureau | Jul 13, 2021 | Facts, Health, Non-Life, Policy

WASHINGTON: Medicare on Monday launched a formal process to decide whether to cover Aduhelm, the new Alzheimer's drug whose $56,000-a-year price tag and unproven benefits have prompted widespread criticism and a congressional investigation. A final decision...
« Older Entries
Next Entries »

Recent Posts

  • Iran declares Hormuz closure over Lebanon fighting, US says waterway remains open
  • Repo Deals, G-Sec Lending: IRDAI recasts insurers’ investment playbook
  • Insurance intermediaries must report big commission payments, Publish details online: IRDAI
  • Lloyd’s:A new marine war risk consortium launched to support Strait of Hormuz shipping
  • IRDAI constitutes expert panel to chart AI roadmap for insurance sector

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy